
Arthur
19.2K posts

Arthur
@TheRoundTable24
F.Y.F.•Zero Fs given• I lost my filter in Butler,Pennsylvania 🇺🇸



BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal 84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION. Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995. The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology. A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole. Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability. At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either: No evidence of disease (32.8%) Tumor regression (15.6%) or Cancer stabilization (36.1%) Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months. Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments. This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential. With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required. In the meantime, many cancer patients are exercising their right to try. @twc_health @McCulloughFund @IIAR_Journals @P_McCulloughMD @DrHarveyRisch @DrKellyVictory @jathorpmfm @drdrew @PeterGillooly @FosterCoulson


🚨“WE WILL FIND HIM.” Acting AG @DAGToddBlanche responds after an individual allegedly threatened to murder an I.C.E. officer, his wife, and children. Todd Blanche says threats against law enforcement families cross a line — and federal prosecutors are treating it as a serious crime. The DOJ says accountability is coming.

Jennifer Lopez’ non-binary daughter comes out as TRANS and changes her name to identify as a ‘man.’ The singers daughter Emme, who previously identified as non-binary, using They/Them pronouns, now identifies as trans using the male name Oskar. Source: Daily Mail




@mattgaetz She doesn't need to worry. LA uses "Voting Solutions for All People" created by Smartmatic. The winner has already been chosen.




#Giants QB Jaxson Dart addressed teammates in a meeting yesterday to discuss his introduction of President Trump last week, sources tell me and @RapSheet. Other team leaders spoke up as well, and Dart and the players worked through it. They are moving forward.

Our GOP Senate sucks! Why are we paying our enemy’s $40,000,000.00 a week to hate us? Why are we not passing secure election laws?


What a horrible woman.


BREAKING: Karen Bass collapses >10 points in the LA Mayoral Election odds, as Spencer Pratt continues to gain momentum. 5 days until Election Day.


We're all being robbed. We're all angry. It's time we focused that anger where it belongs.


JUST IN: Zelenskyy has reportedly warned Trump that Ukraine is facing a “critical shortage” of air-defense missiles.












